41/72US=11 / Transplante
Torlakovic EE, Naresh KN, Brunning RD. Cluster of differentiation markers. In: ___. Bone marrow immunohistochemistry. Chicago: American Society for Clinical Nutrition, 2009. p. 13-152. ISBN 978-0891895725.

TRANSPLANTE; IMUNISTOQUIMICA; MEDULA OSSEA; MARCADORES; GRUPO DE DIFERENCIACAO; CD1A; CD2; CD3; CD4; CD5; CD7; CD8; CD9; CD10; CD14; CD15; CD16; CD20; CD21; CD22; CD23; CD25; CD30; CD31; CD33; CD34; CD35; CD45; CD56; CD57; CD61; CD42B; CD68; CD79A; CD99; CD117; CD123; CD138; CD235A; GLYCOPHORIN A

42/72US=11 / Transplante
Torlakovic EE, Naresh KN, Brunning RD. Other common markers. In: ___. Bone marrow immunohistochemistry. Chicago: American Society for Clinical Nutrition, 2009. p. 153-236. ISBN 978-0891895725.

TRANSPLANTE; IMUNISTOQUIMICA; MEDULA OSSEA; MARCADORES; MIELOPEROXIDASE; HEMOGLOBINA A; HGBA; TRIPTASE DE MASTOCITOS; DESOXINUCLEOTIDIL TRANSFERASE TERMINAL; TDT; ANTIGENO RELACIONADO AO FATOR 8; FATOR DE VON WILLEBRAND; PAX-5; PU.1; FLI-1; CICLINA D1; LISOZIMA; BCL-6; IMUNOGLOBINAS; KI-67; MOLECULAS CITOTOXICAS; MARCADORES DE ESTROMA; MUM1; TRAP; BCL-2

43/72US=11 / Transplante
Torlakovic EE, Naresh KN, Brunning RD. Special diagnostic considerations. In: ___. Bone marrow immunohistochemistry. Chicago: American Society for Clinical Nutrition, 2009. p. 237-55. ISBN 978-0891895725.

TRANSPLANTE; IMUNISTOQUIMICA; MEDULA OSSEA; LEUCEMIA AGUDA; METASTASES

44/72US=14 / Câncer
Bukhari MH, Niazi S, Anwar M, Chaudhry NA, Naeem S. Prognostic significance of new immunohistochemistry scoring of p53 protein expression in cutaneous squamous cell carcinoma of mice. In: Branicki FJ, Adem A, Ghazal-Aswad S, Torab FC. Recent advances in clinical oncology. Boston: Blackwell, 2008. p. 1-9. ISBN 978-1-57331-700-9.

IMUNOHISTOQUIMICA; P53; CARCINOMA DE CELULAS ESCAMOSAS

45/72US=14 / Câncer
Lireza A, Raheleh S, Abbass R, Mojgan M, Mohamadreza M, Gholamreza M, Shadi B. An immunohistochemistry study of tissue bcl-2 expression and its serum levels in breast cancer patients. In: Branicki FJ, Adem A, Ghazal-Aswad S, Torab FC. Recent advances in clinical oncology. Boston: Blackwell, 2008. p. 114-20. ISBN 978-1-57331-700-9.

CANCER DE MAMA; EXPRESSAO BCL-2; IMUNOHISTOQUIMICA

46/72US=17 / Pelvis
Folpe AL, Gown AM. Immunohistochemistry for analysis of soft tissue tumors. In: Weiss SW, Goldblum JR. Enzinger and Weiss's soft tissue tumors. 5th ed. Philadelphia: Elsevier Mosby, 2008. p. 129-74. ISBN 978-0-323-04628-2.

IMUNOHISTOQUIMICA; TUMORES EM TECIDOS MOLES; FILAMENTOS INTERMEDIARIOS; VIMENTINA; CITOQUERATINAS; ANTIGENO DE MEMBRANA EPITELIAL; MARCADORES DE DIFERENCIACAO MUSCULAR; DESMINA; ACTINA; FATORES DE TRANSCRICAO MIOGENICOS; MARCADORES DA BAINHA DOS NERVOS; MARCADORES NEUROECTODERMAL; MARCADORES DE MELANOCITICOS; MARCADORES DE ENDOTELIO; MESOTELIOMA; CARCINOMA; MARCADORES DE TUMORES GASTROINTESTINAIS ESTROMAIS; MARCADORES PROGNOSTICOS

47/72US=23 / Câncer
Tan PH, Tse GMK, Yip GWC, Bay BH. Phyllodes tumours of the breast: the role of immunohistochemistry in diagnosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 251-62. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TUMOR PHYLLODES; IMUNOHISTOQUIMICA; CARACTERISTICAS CLINICO-PATOLOGICAS

48/72US=23 / Câncer
Esposito NN, Dabbs DJ. Phyllodes tumours of the breast: prognostic assessment using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 263-73. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TUMOR PHYLLODES; IMUNOHISTOQUIMICA; AVALIACAO PROGNOSTICA; MARCADORES DE PROLIFERACAO CELULAR; GENES SUPRESSORES DE TUMOR; P53; RECEPTORES DE ESTEROIDES; PROTEINAS; FATORES DE CRESCIMENTO EPIDERMICO; HER-2/NEU; ANALISE CROMOSSOMICA; ANALISE MOLECULAR; ANALISE HISTOPATOLOGICA

49/72US=23 / Câncer
Tot T. Metaplastic breast carcinoma: detection using histology and immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 275-90. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CARCINOMA DE MAMA METAPLASICO; HISTOLOGIA; IMUNOHISTOQUIMICA; CARACTERISTICAS CLINICO-PATOLOGICAS; PROGNOSTICO

50/72US=23 / Câncer
van Diest PJ, Moelans CB, Purnomosari D, Pals G, de Weger RA. Invasive breast cancer: overexpression of HER-2 determined by immunohistochemistry and multiplex ligation-dependent probe amplification. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 291-304. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA INVASIVO; SUPEREXPRESSAO DE HER-2; IMUNOHISTOQUIMICA; LIGADURA MULTIPLEX DEPENDENTE

51/72US=23-A / Câncer
Hiroshima K. Pathological distinction of pulmonary large cell neuroendocrine carcinoma from small-cell lung carcinoma using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 349-61. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; CARCINOMA PULMONAR DE CELULAS GRANDES; CARCINOMA DE PULMAO DE PEQUENAS CELULAS; IMUNOHISTOQUIMICA; CARCINOMA DE GRANDES CELULAS NEUROENDOCRINO; MORFOMETRIA; BIOLOGIA MOLECULAR

52/72US=23-A / Câncer
Zander DS, Clarke LE. Differentiation between pleuropulmonary desmoid tumors and solitary fibrous tumors: role of histology and immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 363-9. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; TUMORES PLEUROPULMONARES DESMOIDE; TUMORES FIBROSOS SOLITARIOS; HISTOLOGIA; IMUNOHISTOQUIMICA; PATOLOGIA MACROSCOPICA; PATOLOGIA MICROSCOPICA

53/72US=23-C / Câncer
Atkin GK, Wilson GD. Rectal cancer: spectral imaging and immunohistochemistry of thymidylate synthase. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 329-39. ISBN 978-1-4020-9544-3.

CANCER COLORRETAL; CANCER DE RETAL; CANCER DE RETO; DIAGNOSTICO; IMAGEM ESPECTRAL; IMUNOHISTOQUIMICA; TIMIDILATO SINTASE

54/72US=23-C / Câncer
Owens SR. Anal squamous cell carcinomas: diagnosis using p63 immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 463-70. ISBN 978-1-4020-9544-3.

CANCER COLORRETAL; CANCER DE ANUS; CARCINOMAS ESCAMOSOS DE CELULAS ANAL; DIAGNOSTICO; IMUNOHISTOQUIMICA; P63

55/72US=47 / Biol/Mol
Hunt J, Davydova L, Cartun RW, Baiulescu M. Immunohistochemistry. In: Coleman WB, Tsongalis GJ. Molecular diagnostics: for the clinical laboratorian. 2ª ed. Totowa: Humana Press, 2006. p. 203-17. ISBN 1-58829-356-4.

DIAGNOSTICO MOLECULAR; IMUNOHISTOQUIMICA; ANTICORPOS; TECNICAS IMUNOHISTOQUIMICAS; DIAGNOSTICO TUMORAL

56/72Câncer
Soares FD, Barroso DRC, Balassiano KZ, Silva LE, Fonseca EC, Lourenço SQC. Immunohistochemistry for Ki67, Bcl-2 and p53 in oral leukoplakias diferentes noncancerous states. Applied Cancer Research, São Paulo: Tecmedd, v.33, n.4, p. 173-179, 2013. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR2013;33(4)p.173-9.pdf

57/72US=2 / Patologia
Hayat MA. Immunohistochemistry and in situ hybridization of human carcicomas: molecular pathology, colorectal carcinoma and prostate carcinoma. San Diego: Elsevier academic press, 2005. 492 p. ISBN 0-12-3339-421.

CARCICOMAS; MOLECULAR; PATOLOGIA; COLORETAL; CARCINOMA E PROSTATA; CARCINOMA HISTOPATOLOGIA; ANATOMIA PATOLOGICA; TUMORES

58/72US=37 / Patologia
Sun T. Flow cytometry and immunohistochemistry for hematologic neoplasms. 2 ed. Philadelphia: Wolters Kluwer, 2008. 335 p. ISBN 978-0-7817-8400-9.

CITOMETRIA DE FLUXO; IMUNOISTOQUIMICA; HEMATOLOGIA; CANCER

59/72US=459 / Tese/FAP
Spagnul SJT. Análise por imunoistoquímica das proteínas p53, PRB, HER-2 e ciclina D1 em tumores vesicais em pacientes submetidos a cistectomia radical. [Immunohistochemistry analysis of p53, pRb, Erb-2 and Cyclin D1 in bladder tumors in patients undergoing radical cystectomy]. São Paulo, 2013. 101 p. Dissertação(Mestrado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2013/SamuelSpagnul/SamuelSpagnul.pdf

Curriculum Lattes

NEOPLASIAS DA BEXIGA URINARIA; CICLINA D1; CISTECTOMIA; PROTEINA SUPRESSORA DE TUMOR P53; IMUNOISTOQUIMICA

60/72US=245 / Tese/FAP
Natalino RJM. Estudo das proteínas que regulam a apoptose no retinoblastoma de pacientes submetidos à enucleação ou exenteração ao diagnóstico. [Study of the proteins that regulate the apoptosis in the retinoblastoma of patients who underwent enucleation at diagnosis]. São Paulo, 2009. 110 p. Dissertação(Mestrado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2009/RenatoNatalino/RenatoNatalino.pdf

Curriculum Lattes

RETINOBLASTOMA; APOPTOSE; PROTEINA SUPRESSORA DE TUMOR P53; PROTEINAS BCL-2 PROTO-ONCOGENICAS; IMUNOHISTOQUIMICA; CASPASE 3

Primeira | Anterior | Próxima | Última